This study is being done to determine 1) whether drugs to treat cisplatin-related nausea can
influence harm to the kidneys, 2) whether cisplatin levels in the body can influence the risk
of harm to the kidneys, and 3) whether a person's genetic make-up can increase or decrease
the likelihood of kidney injury due to cisplatin therapy.
Phase:
N/A
Details
Lead Sponsor:
University of Colorado, Denver
Collaborators:
Memorial Sloan Kettering Cancer Center National Institute of General Medical Sciences (NIGMS) Rutgers University